 |
|
|
|
|
|
|
 |
- Abraxane
- Adriamycin
- Alimta
- Altraz
- Alectinib
- Anti-Cancer Drugs
- Anti-D
- Arimidex
- Aromasin
- ATGAM
- Atezolizumab
- Avastin
- Avonex
- Bendamustine
- Biomab
- Bortenat
- Caelyx
- Carmustine
- Chlorambucil
- Crizalk
- Climax Spray
- Cobimetinib
- Dacogen
- Dacotin
- Daclavir
- Docefrez
- Docetax
- Daratumumab
- Erbitux
- Erlonat
- Exemestane
- Elotuzumab
- Farmorubicin
- Femara
- Fludarabine
- Fulvestrant
- Gazyva
- Geftinat
- Gemcite
- Gemtaz
- Gleevac
- Grafeel
- Halaven
- Herceptin
- Hydrea
- Hepcinat
- Imatib
- Inlyta
- Ixempera
- Ixempra
- Irinotecan (Liposomal)
- Ixazomib
- Jevtana
- Kadcyla
- L-asparaginase
- Lenalid
- Lipodox
- Lenvatinib
- Lucentis
- Lonsurf
- Mabthera
- Melphalan Tablets
- Myezom
- Navelbine
- Neulastim
- Neupogen
- Necitumumab
- Oncology Drugs
- Osimertinib
- Onivyde
- Paclitax
- Paraplatin
- Pegasys
- Pemgem
- Pemnat
- Perjeta
- Pirfenex
- Pomalidomide
- Reditux
- Sandostatin
- Sorafenib
- Sovaldi
- Sprycel
- Sutent
- Stivarga
- Stribild
- Tasigna
- Taxol
- Taxotere
- Temolon
- Temoside
- Thalix
- Treosulfan
- Tykerb
- Veenat
- Vlcade
- Venetoclax
- Xeloda
- Yondelis
- Zoldria
- Zometa
- Zytiga
 |
|
|
 |
Pemgem
Generic Content-Pemetrexed, Manufactured By:
Dr.Reddy’s Lab,India
Pemgem is approved by the FDA for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy and whose disease has not worsened. Pemgem is not indicated for patients who have a different type of NSCLC called squamous cell.
Available As: 100 Mg & 500 Mg.
Pemgem is approved by the FDA for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy and whose disease has not worsened. Pemgem is not indicated for patients who have a different type of NSCLC called squamous cell.
Available As: 100 Mg & 500 Mg.